BRIEF-FDA grants orphan drug exclusivity to Spectrum Pharmaceutical's Evomela(tm)

* FDA grants orphan drug exclusivity to Evomela(tm) (melphalan) for injection, indicated for multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.